New psoriasis injection seeks to clear skin in major trial
Disease control
Recruiting now
This study is testing an experimental injection called HB0017 for people with moderate to severe plaque psoriasis. It aims to find the best dosing schedule by measuring how much it improves skin symptoms and how safe it is. About 200 participants will be randomly assigned to rece…
Phase: PHASE2 • Sponsor: Huabo Biopharm Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC